Ensure Logo-1

FOR UK HEALTHCARE PROFESSIONALS

This website is designed specifically for healthcare professionals in the UK. Please confirm that you are currently working in or representing someone from the healthcare industry.

© 2020 Abbott. All Rights Reserved. Please read the Legal Notice for further details. Unless otherwise specified, all product and services names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, tradename, or trade dress in the site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

UK-ENSC-2000012 May 2020

THE VALUE OF MUSCLE IN IMPROVING CLINICAL OUTCOMES

 

Ione Ashurst, Nutrition Lead, Royal Brompton Hospital, London

Executive summary

Skeletal muscle represents about 40% of the human body weight and is responsible for movement and postprandial glucose processing.1, 2 It is the principal protein reservoir to replace blood amino acids,3 the precursors for hepatic gluconeogenesis.4 Adequate muscle mass is paramount to maintain plasma glucose concentration, conversely, depletion is incompatible with life. Warsaw ghetto studies suggest that death from starvation occurs when muscle protein breakdown becomes inadequate to maintain supply of gluconeogenic precursors.5 Losing muscle occurs naturally with age and can lead to decreased strength and functionality. After 30 years of age, there is a shift towards degeneration, leading to a net loss of muscle mass and strength.6 This muscle wasting in ageing, but otherwise healthy individuals, is referred to as sarcopenia.

Download the full article

References:

1. Brook MS, et al. (2016). Skeletal muscle homeostasis and plasticity in youth and ageing: impact of nutrition and exercise. Acta Physiol.; 216: 15-41. 2. Ciaraldi TP, et al. (2016) Altered myokine secretion is an intrinsic property of skeletal muscle in type 2 diabates. PloS One.; 11: e0158209. 3. Felig P, Owen OE & Wahren J. (1969). Amino acid metabolism during prolonged starvation. J. Clin. Investig.; 48: 584-94. 4. Felig P. (1973). The glucose alanine cycle. Metab.; 22: 179-88. 5. Winick M. Hunger disease. Studies by the Jewish Physicians in the Warsaw Ghetto. New York (USA): Wiley & Sons; 1979. 6. Ekinci O et al. Nutr Clin Pract 2016; 31(6):829-835.